Journal
HEPATOLOGY RESEARCH
Volume 42, Issue 2, Pages 150-165Publisher
WILEY
DOI: 10.1111/j.1872-034X.2011.00905.x
Keywords
5-fluorouracil; FAIT; hepatic arterial infusion chemotherapy; hepatocellular carcinoma; interferon-a; portal vein
Categories
Funding
- Otsuka Pharmaceutical
Ask authors/readers for more resources
Aim: The efficacy and safety of 5-fluorouracil arterial infusion + interferon therapy (FAIT) was evaluated in patients with hepatocellular carcinoma (HCC) with a high degree of vascular invasion associated with poor prognosis, using best salvage therapy (BST) as a reference group.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
